Y. Cheung, Ph.D., founder, president and
CEO of Medifocus.“With Prolieve, Medifocus now transforms from a development
stage cancer treatment medical device
company to a mature medical treatment
systems and devices company with a rev-enue-generating commercial product for
treatment of BPH and an innovative focused-heat breast cancer treatment system
in advanced Phase III clinical development.
Using the Prolieve technology platform
and the APA focused-heat platform, the
Company is well positioned to develop a
rich pipeline of minimally invasive and side
effect-free focused-heat treatment systems
and devices for cancer and other diseases.”
Medifocus is based in Columbia, Md. The
company develops and commercializes
minimally invasive, focused-heat tumor-tar-geted cancer treatment devices and systems.
Boston Scientific provides technology in
the cardiology, endoscopy, urology, women’s
health and neuromodulation sectors.
Becker & Associates Consulting
Acquired by NSF International
NSF International, an independent global
public health and safety organization that
develops standards, tests, and certifies
products for the food, water, health and
consumer products industries, has acquired Becker & Associates Consulting
Inc., a clinical, regulatory and scientific
consulting firm that specializes in U.S.
Food and Drug Administration (
FDA)-reg-ulated industries, specifically medical devices, pharmaceuticals and biologics.
Terms of the deal were not disclosed.
Becker will become part of NSF’s
Health Sciences Division, which offers
training and education, consulting, good
manufacturing practice and good labora-
tory practice testing, certification, research
and development and auditing services for
the pharmaceutical, dietary supplement
and medical device industries throughout
the entire product lifecycle.